ACP5 and Osteopenia: Zidovudine and lamivudine stimulate osteoclastogenesis in vitro and cause osteopenia in mice by increasing the promoter activity of tartrate-resistant acid phosphatase and the binding of nuclear factor-kappa B (Pan et al., 2004; Pan et al., 2006).